Skip to main content
Back to AI NewsNews

UK Surgeons Deploy AI Colour-Coding Tool in First Clinical Use

An AI system that colour-codes anatomical structures in real time during surgery has been used for the first time in the United Kingdom.

cueball EditorialTuesday, 9 June 2026 3 min read

What Happened

An artificial intelligence tool that identifies and colour-codes distinct parts of the human anatomy in real time during surgical procedures has been deployed for the first time in the United Kingdom. The system operates alongside robotic and laparoscopic surgery platforms, overlaying highlighted anatomical labels onto live surgical footage displayed on a screen during operations.

How the Technology Works

The tool processes live video feeds generated by laparoscopic or robotic surgical cameras. As surgery proceeds, the AI identifies individual anatomical structures and assigns each a distinct colour code, making different body parts visually distinguishable to surgeons on screen in real time. The system does not replace the surgical instruments or robotic platforms in use. It functions as an additional visual layer integrated into the existing display infrastructure in the operating theatre.

The approach is designed to reduce the risk of surgeons inadvertently cutting or damaging structures that are difficult to distinguish from surrounding tissue, particularly in minimally invasive procedures where the operative field is viewed entirely through a camera.

Background

Minimally invasive surgery, including laparoscopic and robotic-assisted procedures, has expanded significantly over the past two decades. In these procedures, surgeons operate through small incisions using elongated instruments and cameras rather than open cuts, which reduces recovery times and surgical trauma. However, the camera-mediated view can make it harder to distinguish adjacent structures, such as bile ducts, blood vessels, or nerves, from surrounding tissue, particularly when anatomy varies between patients or is obscured by inflammation or fat.

Surgical AI tools have been an active area of development across several medical technology companies. Real-time intraoperative guidance systems have been explored in research settings for several years, with some tools reaching clinical deployment in the United States and parts of Europe ahead of this UK introduction.

The UK Deployment

The specific clinical site and surgical team involved in the UK first use were identified in the report. The procedure marks the first documented clinical application of this colour-coding AI guidance system within the National Health Service or a UK surgical setting, according to the available reporting. No details on patient outcomes from the initial procedure were included in the wire report at the time of publication.

The system's introduction into UK surgical practice follows a broader pattern of AI-assisted tools entering operating theatres across different countries. Regulatory clearance for medical AI devices in the UK is overseen by the Medicines and Healthcare products Regulatory Agency, which evaluates such tools as medical devices.

What It Means in Practice

Surgeons using laparoscopic or robotic platforms typically rely on tactile feedback, anatomical knowledge, and visual inspection of camera footage to navigate tissue during an operation. A real-time colour-coding overlay provides an additional reference point that does not require the surgeon to pause or consult a separate imaging system. The tool operates continuously as the procedure progresses.

The technology has potential application across a range of abdominal and thoracic procedures where clear identification of structures such as the ureter, bile duct, or major vessels is critical to avoiding injury. The extent to which the system has been validated across different procedure types, patient populations, and surgical conditions was not detailed in the available reporting.

What Happens Next

Further clinical deployments of the system at additional UK surgical centres are expected to follow the initial procedure, with outcome data from those cases likely to inform broader adoption decisions within NHS trusts.

Get our editors' take on what it all means. Read the Editor's Blog →